Last 48 quarters of trend data · Healthcare · Medical - Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -5.39 | — | — | — | — | — | — | 789.91 | — | — | — | — | — | — | — | — | — | — | — | 235.19 | 331.61 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +116.3% | — | |
| P/S Ratio | 1.11 | 1.01 | 1.33 | 1.29 | 0.82 | 1.30 | 1.36 | 2.11 | 1.91 | 2.95 | 3.02 | 2.46 | 1.82 | 2.03 | 3.87 | 3.28 | 3.76 | 4.73 | 10.56 | 11.81 | 10.76 |
| — | -21.9% | -2.3% | -38.9% | -56.9% | -56.0% | -55.0% | -14.2% | +5.0% | +45.3% | -22.0% | -25.1% | -51.5% | -57.1% | -63.4% | -72.2% | -65.1% | -49.0% | +8.1% | +26.4% | -23.8% | |
| P/B Ratio | 7.10 | 7.92 | 9.90 | 9.63 | 6.18 | 9.38 | 8.19 | 9.06 | 11.69 | 11.20 | 9.52 | 6.17 | 4.31 | 4.83 | 7.74 | 6.58 | 7.29 | 8.44 | 16.98 | 22.91 | 19.85 |
| — | -15.6% | +20.9% | +6.4% | -47.2% | -16.3% | -13.9% | +46.9% | +171.5% | +131.7% | +23.0% | -6.3% | -40.9% | -42.7% | -54.4% | -71.3% | -63.3% | -54.3% | -3.4% | +33.6% | -7.2% | |
| P/FCF | — | — | 68.49 | 120.40 | 49.21 | — | — | 77.90 | 32.26 | — | — | — | — | — | — | 3748.78 | 75.09 | — | 166.46 | 178.62 | 62.27 |
| — | — | — | +54.6% | +52.6% | — | — | — | — | — | — | — | — | — | — | +1998.8% | +20.6% | — | +204.0% | +26.7% | -72.5% | |
| EV / EBITDA | — | — | — | 38.48 | — | — | — | 190.23 | — | — | — | — | — | — | — | — | — | — | — | 156.34 | 178.45 |
| — | — | — | -79.8% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +115.2% | -80.0% | |
| EV / EBIT | — | — | — | 72.84 | — | — | — | 371.44 | — | — | — | — | — | — | — | — | — | — | — | 207.93 | 286.51 |
| — | — | — | -80.4% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +179.5% | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 52.3% | 56.9% | 55.3% | 57.7% | 53.9% | 52.3% | 50.5% | 55.7% | 34.3% | 50.8% | 49.4% | 47.4% | 48.4% | 51.9% | 48.9% | 52.4% | 51.1% | 50.9% | 51.8% | 54.2% | 53.9% |
| — | +8.8% | +9.5% | +3.5% | +57.0% | +2.9% | +2.3% | +17.5% | -29.0% | -2.1% | +0.9% | -9.5% | -5.3% | +2.0% | -5.5% | -3.3% | -5.2% | -5.2% | -0.3% | +0.5% | +1.9% | |
| Operating Margin | -7.7% | -5.4% | -7.1% | 2.9% | -8.0% | -21.5% | -51.6% | -0.2% | -7.2% | -13.9% | -21.7% | -17.8% | -17.0% | -19.8% | -75.5% | -8.1% | -23.2% | -6.1% | -8.7% | 6.1% | 4.3% |
| — | +74.8% | +86.3% | +1487.2% | -12.1% | -55.2% | -137.1% | +98.8% | +57.7% | +30.0% | +71.2% | -121.0% | +26.8% | -224.1% | -765.4% | -232.9% | -640.2% | -293.7% | -279.9% | -45.4% | +626.5% | |
| Net Margin | -20.2% | -8.3% | -8.2% | -0.2% | -8.5% | -21.8% | -55.7% | 0.3% | -6.4% | -13.9% | -22.3% | -15.2% | -17.8% | -18.3% | -73.1% | -7.2% | -23.9% | -7.5% | -8.4% | 5.1% | 3.2% |
| — | +61.8% | +85.2% | -175.9% | -32.7% | -56.8% | -149.9% | +101.8% | +64.0% | +24.0% | +69.5% | -112.0% | +25.8% | -142.9% | -774.2% | -239.7% | -842.2% | -422.9% | -133.9% | -49.1% | +142.4% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -97.9% | -16.1% | -14.2% | -0.4% | -15.9% | -36.3% | -62.4% | 0.3% | -9.9% | -12.9% | -15.3% | -9.6% | -10.2% | -10.7% | -31.8% | -3.7% | -11.2% | -3.4% | -3.4% | 2.6% | 1.6% |
| — | +55.6% | +77.3% | -235.6% | -61.2% | -181.1% | -306.7% | +103.2% | +3.8% | -20.6% | +51.8% | -159.8% | +8.8% | -215.5% | -841.1% | -240.0% | -813.6% | -379.3% | -127.8% | -46.5% | +149.7% | |
| ROA | -22.1% | -1.8% | -2.0% | -0.1% | -2.4% | -5.8% | -13.8% | 0.1% | -2.5% | -3.3% | -4.5% | -3.2% | -3.5% | -3.8% | -12.3% | -1.5% | -4.7% | -1.5% | -1.5% | 1.2% | 0.7% |
| — | +68.5% | +85.5% | -185.6% | +1.4% | -77.7% | -206.3% | +102.5% | +29.8% | +12.8% | +63.5% | -110.0% | +25.6% | -156.5% | -705.5% | -222.6% | -767.3% | -383.7% | -123.4% | -49.7% | +148.2% | |
| ROIC | -10.0% | -1.4% | -2.0% | 1.1% | -3.0% | -7.0% | -14.4% | -0.1% | -2.9% | -3.5% | -4.7% | -4.0% | -3.7% | -4.7% | -14.5% | -1.9% | -4.8% | -1.2% | -1.6% | 1.5% | 1.0% |
| — | +80.2% | +86.2% | +1797.1% | -1.2% | -100.4% | -206.0% | +98.4% | +20.8% | +25.2% | +67.7% | -109.8% | +22.8% | -285.4% | -809.7% | -225.9% | -582.4% | -259.5% | -232.9% | -50.4% | +556.6% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 2.86 | 5.67 | 5.55 | 3.64 | 3.38 | 3.37 | 3.18 | 1.80 | 2.00 | 2.04 | 1.96 | 1.33 | 1.33 | 1.28 | 1.24 | 0.95 | 1.00 | 0.94 | 0.96 | 0.73 | 0.81 |
| — | +68.3% | +74.7% | +102.1% | +68.8% | +65.1% | +61.7% | +35.8% | +50.3% | +59.8% | +58.3% | +38.9% | +33.1% | +36.0% | +29.5% | +31.4% | +23.4% | +2.4% | -5.7% | +16.6% | +17.0% | |
| Debt / EBITDA | — | — | — | 44.13 | — | — | — | 129.28 | — | — | — | — | — | — | — | — | — | — | — | 19.35 | 28.41 |
| — | — | — | -65.9% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +87.2% | -75.1% | |
| Current Ratio | 2.55 | 3.18 | 3.58 | 2.55 | 2.44 | 2.44 | 2.30 | 2.93 | 2.90 | 3.05 | 3.81 | 3.83 | 4.05 | 4.38 | 4.43 | 5.14 | 4.81 | 6.00 | 6.21 | 6.15 | 6.31 |
| — | +30.2% | +55.4% | -13.2% | -15.9% | -19.9% | -39.6% | -23.4% | -28.3% | -30.3% | -14.0% | -25.5% | -15.7% | -27.0% | -28.7% | -16.4% | -23.8% | -6.6% | -3.0% | +0.3% | +12.4% | |
| Quick Ratio | 2.02 | 2.65 | 3.07 | 2.02 | 1.90 | 1.88 | 1.81 | 2.33 | 2.32 | 2.38 | 3.01 | 3.02 | 3.28 | 3.53 | 3.66 | 4.47 | 4.20 | 5.36 | 5.60 | 5.63 | 5.76 |
| — | +41.0% | +69.3% | -13.4% | -18.0% | -21.0% | -39.8% | -23.0% | -29.5% | -32.7% | -17.7% | -32.4% | -21.8% | -34.2% | -34.7% | -20.7% | -27.1% | -7.7% | -2.6% | +2.0% | +16.5% | |
| Interest Coverage | -24.33 | -7.43 | -11.21 | 3.26 | -11.18 | -21.75 | -88.97 | 1.01 | -11.13 | -15.59 | -20.08 | -16.42 | -5.49 | -20.58 | -74.97 | -9.52 | -29.04 | -7.72 | -10.13 | 7.83 | 4.58 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying TNDM stock.
Tandem Diabetes Care, Inc.'s current P/E is -5.4x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Tandem Diabetes Care, Inc.'s current operating margin is -7.7%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Tandem Diabetes Care, Inc.'s business trajectory between earnings reports.